Target Name: 3-Ketoacyl-CoA Thiolase (3-KAT)
NCBI ID: P41842
Other Name(s): 3-Ketoacyl-CoA Thiolase | 3-KAT

3-KAT: A Potential Drug Target for Energy Metabolism

3-Ketoacyl-CoA Thiolase (3-KAT) is an enzyme that plays a crucial role in the metabolism of fatty acids and ketones. It is a key enzyme in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA ) cycle, which is responsible for generating energy in the form of ATP from the food we eat.

3-KAT is a protein that is expressed in most tissues of the body and is involved in the citric acid cycle. It is a subunit of the TCA cycle and is localized to the mitochondria. 3-KAT catalyzes the conversion of 3-ketoacyl- CoA (3-KAC) to 2-ketoglutarate (2-KET) via a series of intermediate steps.

The 3-KAT enzyme has been identified as a potential drug target in the field of metabolism and diseases. Its role in the TCA cycle makes it a promising target for interventions that target energy metabolism and the associated diseases, such as obesity, diabetes, and fatty liver diseases.

3-KAT has been shown to be involved in the regulation of energy metabolism and has been linked to the development and progression of several diseases. For example, 3-KAT has been shown to be involved in the development of obesity and non-alcoholic fatty liver disease (NAFLD).

In addition to its potential as a drug target, 3-KAT has also been shown to be a valuable biomarker for monitoring the progression of certain diseases. For example, the levels of 3-KAT have been shown to be elevated in the blood of obese individuals compared to those who are normal weight.

3-KAT has also been shown to be involved in the regulation of cellular signaling pathways. For example, 3-KAT has been shown to be involved in the regulation of the unfolded protein response (UPR), a signaling pathway that is involved in the regulation of protein structure and function.

In conclusion, 3-Ketoacyl-CoA Thiolase (3-KAT) is a protein that plays a crucial role in the metabolism of fatty acids and ketones. Its role in the TCA cycle makes it a promising target for interventions that target energy metabolism and the associated diseases. Its potential as a drug target and biomarker make it an attractive target for future research.

Protein Name: 3-Ketoacyl-CoA Thiolase (3-KAT) (nonspecified Subtype)

More Common Targets

39S ribosomal subunit, mitochondrial | 4EHP-GYF2 complex | 5-Hydroxytryptamine Receptor | 5-Hydroxytryptamine Receptor 1 (5-HT1) | 5-Hydroxytryptamine Receptor 2 (5-HT2) | 60S Ribosome | 9-1-1 cell-cycle checkpoint response complex | A-Kinase Anchor Proteins | A1BG | A1BG-AS1 | A1CF | A2M | A2M-AS1 | A2ML1 | A2MP1 | A3GALT2 | A4GALT | A4GNT | AAAS | AACS | AACSP1 | AADAC | AADACL2 | AADACL2-AS1 | AADACL3 | AADACL4 | AADACP1 | AADAT | AAGAB | AAK1 | AAMDC | AAMP | AANAT | AAR2 | AARD | AARS1 | AARS2 | AARSD1 | AASDH | AASDHPPT | AASS | AATBC | AATF | AATK | ABALON | ABAT | ABCA1 | ABCA10 | ABCA11P | ABCA12 | ABCA13 | ABCA17P | ABCA2 | ABCA3 | ABCA4 | ABCA5 | ABCA6 | ABCA7 | ABCA8 | ABCA9 | ABCB1 | ABCB10 | ABCB11 | ABCB4 | ABCB5 | ABCB6 | ABCB7 | ABCB8 | ABCB9 | ABCC1 | ABCC10 | ABCC11 | ABCC12 | ABCC13 | ABCC2 | ABCC3 | ABCC4 | ABCC5 | ABCC6 | ABCC6P1 | ABCC6P2 | ABCC8 | ABCC9 | ABCD1 | ABCD2 | ABCD3 | ABCD4 | ABCE1 | ABCF1 | ABCF1-DT | ABCF2 | ABCF3 | ABCG1 | ABCG2 | ABCG4 | ABCG5 | ABCG8 | ABHD1 | ABHD10 | ABHD11